EE201300004A - Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks - Google Patents
Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviksInfo
- Publication number
- EE201300004A EE201300004A EEP201300004A EEP201300004A EE201300004A EE 201300004 A EE201300004 A EE 201300004A EE P201300004 A EEP201300004 A EE P201300004A EE P201300004 A EEP201300004 A EE P201300004A EE 201300004 A EE201300004 A EE 201300004A
- Authority
- EE
- Estonia
- Prior art keywords
- diseases
- treatment
- conditions
- pharmaceutical composition
- cardiovascular system
- Prior art date
Links
- 210000000748 cardiovascular system Anatomy 0.000 title 1
- 201000010099 disease Diseases 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2869—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against hormone receptors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
- A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2803—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/40—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against enzymes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
- A61K2039/507—Comprising a combination of two or more separate antibodies
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Alternative & Traditional Medicine (AREA)
- Endocrinology (AREA)
- Neurosurgery (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Psychiatry (AREA)
- Pain & Pain Management (AREA)
- Diabetes (AREA)
- Hospice & Palliative Care (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| RU2010129292/15A RU2523557C2 (ru) | 2010-07-15 | 2010-07-15 | Способ лечения вегетососудистой дистонии и фармацевтическая композиция для лечения вегетососудистой дистонии |
| RU2010129290/15A RU2525155C2 (ru) | 2010-07-15 | 2010-07-15 | Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для комплексной терапии хронической сердечной недостаточности |
| RU2010129291/15A RU2525156C2 (ru) | 2010-07-15 | 2010-07-15 | Способ лечения и профилактики артериальной гипертензии и фармацевтическая композиция для лечения артериальной гипертензии |
| RU2011110106/15A RU2523451C2 (ru) | 2011-03-17 | 2011-03-17 | Способ лечения хронической сердечной недостаточности и фармацевтическая композиция для лечения хронической сердечной недостаточности |
| PCT/IB2011/002391 WO2012007846A2 (en) | 2010-07-15 | 2011-07-15 | A combination pharmaceutical composition and methods of treating diseases or conditions associated with the cardiovascular system |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE201300004A true EE201300004A (et) | 2013-08-15 |
Family
ID=44899163
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP201300004A EE201300004A (et) | 2010-07-15 | 2011-07-15 | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks |
Country Status (21)
| Country | Link |
|---|---|
| US (1) | US8703124B2 (ko) |
| EP (1) | EP2593482A2 (ko) |
| JP (1) | JP2013532183A (ko) |
| KR (1) | KR20140009110A (ko) |
| AR (1) | AR084707A1 (ko) |
| AU (1) | AU2011278039B2 (ko) |
| BR (1) | BR112013000779A2 (ko) |
| CA (1) | CA2804969A1 (ko) |
| DE (1) | DE112011102356T5 (ko) |
| DK (1) | DK201370080A (ko) |
| EA (1) | EA201300128A1 (ko) |
| EE (1) | EE201300004A (ko) |
| FR (1) | FR2962654A1 (ko) |
| GB (1) | GB2496795A (ko) |
| IT (1) | ITTO20110640A1 (ko) |
| MX (1) | MX2013000544A (ko) |
| NO (1) | NO20130217A1 (ko) |
| SE (1) | SE1350177A1 (ko) |
| SG (1) | SG187034A1 (ko) |
| UA (1) | UA114699C2 (ko) |
| WO (1) | WO2012007846A2 (ko) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2201255C1 (ru) * | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| RU2309732C1 (ru) * | 2006-03-13 | 2007-11-10 | Олег Ильич Эпштейн | Спрессованная твердая оральная форма лекарственного препарата и способ получения твердой оральной формы лекарственного препарата |
| US9308275B2 (en) * | 2010-07-15 | 2016-04-12 | Oleg Iliich Epshtein | Method of increasing the effect of an activated-potentiated form of an antibody |
| DE112011102362T5 (de) | 2010-07-15 | 2013-04-25 | Oleg Iliich Epshtein | Pharmazeutische Kombinationszusammensetzung und Verfahren zur Behandlung von Erkrankungen oder Zuständen, die mit neurodegenerativen Erkrankungen in Verbindung stehen |
| EA029199B1 (ru) | 2010-07-21 | 2018-02-28 | Олег Ильич Эпштейн | Комбинированная фармацевтическая композиция для лечения синдрома дефицита внимания и гиперактивности и способы лечения синдрома дефицита внимания и гиперактивности |
| RU2013111962A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
| RU2013111961A (ru) | 2013-03-18 | 2014-09-27 | Олег Ильич Эпштейн | Способ определения выраженности модифицирующей активности, ассоциированной с носителем |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4311897A (en) | 1979-08-28 | 1982-01-19 | Union Carbide Corporation | Plasma arc torch and nozzle assembly |
| RU2181297C2 (ru) * | 2000-06-20 | 2002-04-20 | Эпштейн Олег Ильич | Способ лечения патологического синдрома и лекарственное средство |
| RU2201255C1 (ru) | 2001-12-26 | 2003-03-27 | Эпштейн Олег Ильич | Лекарственное средство и способ регуляции сосудистого тонуса |
| UA76639C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування еректильних дисфункцій |
| UA76641C2 (uk) | 2002-08-02 | 2006-08-15 | Олєг Ільіч Епштєйн | Гомеопатичний лікарський засіб та спосіб лікування захворювань передміхурової залози |
| UA76638C2 (en) | 2002-08-02 | 2006-08-15 | Oleh Illich Epshtein | Homeopathic medication based on anti-interferon antibodies and method for treating a pathological syndrome associated with interferon |
| US7229648B2 (en) | 2003-03-14 | 2007-06-12 | Dreyer Lee R | Homeopathic formulations useful for treating pain and/or inflammation |
| JP5239899B2 (ja) | 2008-07-29 | 2013-07-17 | 株式会社リコー | 画像形成装置 |
-
2011
- 2011-07-15 EE EEP201300004A patent/EE201300004A/xx unknown
- 2011-07-15 BR BR112013000779A patent/BR112013000779A2/pt not_active IP Right Cessation
- 2011-07-15 FR FR1156474A patent/FR2962654A1/fr not_active Withdrawn
- 2011-07-15 KR KR1020137003520A patent/KR20140009110A/ko not_active Application Discontinuation
- 2011-07-15 IT IT000640A patent/ITTO20110640A1/it unknown
- 2011-07-15 SE SE1350177A patent/SE1350177A1/sv not_active Application Discontinuation
- 2011-07-15 GB GB1302656.2A patent/GB2496795A/en not_active Withdrawn
- 2011-07-15 US US13/135,882 patent/US8703124B2/en not_active Expired - Fee Related
- 2011-07-15 WO PCT/IB2011/002391 patent/WO2012007846A2/en active Application Filing
- 2011-07-15 JP JP2013519177A patent/JP2013532183A/ja not_active Withdrawn
- 2011-07-15 MX MX2013000544A patent/MX2013000544A/es unknown
- 2011-07-15 DE DE112011102356T patent/DE112011102356T5/de not_active Withdrawn
- 2011-07-15 AU AU2011278039A patent/AU2011278039B2/en not_active Ceased
- 2011-07-15 EA EA201300128A patent/EA201300128A1/ru unknown
- 2011-07-15 EP EP11779851.2A patent/EP2593482A2/en not_active Ceased
- 2011-07-15 CA CA2804969A patent/CA2804969A1/en not_active Abandoned
- 2011-07-15 SG SG2013002282A patent/SG187034A1/en unknown
- 2011-07-15 UA UAA201300107A patent/UA114699C2/uk unknown
- 2011-07-18 AR ARP110102577A patent/AR084707A1/es unknown
-
2013
- 2013-02-08 NO NO20130217A patent/NO20130217A1/no not_active Application Discontinuation
- 2013-02-14 DK DKPA201370080A patent/DK201370080A/da not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DK201370080A (en) | 2013-02-14 |
| UA114699C2 (uk) | 2017-07-25 |
| WO2012007846A2 (en) | 2012-01-19 |
| BR112013000779A2 (pt) | 2016-06-07 |
| JP2013532183A (ja) | 2013-08-15 |
| US8703124B2 (en) | 2014-04-22 |
| GB2496795A (en) | 2013-05-22 |
| US20120251584A1 (en) | 2012-10-04 |
| AU2011278039A1 (en) | 2013-03-07 |
| SE1350177A1 (sv) | 2013-04-12 |
| AU2011278039B2 (en) | 2015-07-23 |
| MX2013000544A (es) | 2013-10-28 |
| ITTO20110640A1 (it) | 2012-01-16 |
| NO20130217A1 (no) | 2013-03-22 |
| GB201302656D0 (en) | 2013-04-03 |
| SG187034A1 (en) | 2013-02-28 |
| KR20140009110A (ko) | 2014-01-22 |
| FR2962654A1 (fr) | 2012-01-20 |
| EA201300128A1 (ru) | 2013-12-30 |
| EP2593482A2 (en) | 2013-05-22 |
| DE112011102356T5 (de) | 2013-04-18 |
| CA2804969A1 (en) | 2012-01-19 |
| AR084707A1 (es) | 2013-06-05 |
| WO2012007846A3 (en) | 2012-04-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LTPA2020510I1 (lt) | Pakeistieji 4-fenil-piridinai, skirti su NK-receptoriumi susijusių ligų gydymui | |
| SMT201700008B (it) | Composizione farmaceutica | |
| SMT201600350B (it) | Composizioni farmaceutiche | |
| DK3246018T3 (da) | Farmaceutisk sammensætning | |
| DK2914248T4 (da) | Farmaceutiske sammensætninger til behandlingen af cftr medierede sygdomme | |
| DK2632493T3 (da) | Lægemiddelindgivelsessammensætninger | |
| DK3400944T3 (da) | Ibat-inhibitorer til behandling af leversygdomme | |
| IL224544B (en) | Compound useful for the treatment of nonsense-mutation-mediated diseases and pharmaceutical composition comprising said compound | |
| SMT201400069B (it) | Formulazione farmaceutica | |
| FI20105641A0 (fi) | Uusi menetelmä mikroselluloosan valmistamiseksi | |
| GT201200303A (es) | Formulaciones farmacéuticas | |
| EE201300005A (et) | Ravimkoostis | |
| DK2654736T3 (da) | Hidtil ukendt farmaceutisk sammensætning | |
| FI20105642A (fi) | Uusi menetelmä mikroselluloosan valmistamiseksi | |
| DK2652652T3 (da) | Medikmentadministration | |
| EE201300004A (et) | Kombineeritud ravimkoostis sdame-veresoonkonnaga seotud haiguste v?i seisundite raviks | |
| DK2627345T3 (da) | Formuleringer til behandling af sygdomme i de øvre luftveje | |
| DK2542224T3 (da) | Oral farmaceutisk sammensætning indeholdende dabigatranetexilat | |
| CO6801722A2 (es) | Composiciones farmacéuticas | |
| BR112013008074A2 (pt) | combinações farmacêuticas | |
| SMT201500005B (it) | Composizione framaceutica inalabile | |
| IT1397838B1 (it) | Composizione per la cura delle piante | |
| SMT201600243B (it) | Composizioni farmaceutiche comprendenti anakinra senza citrato | |
| BR112012029461A2 (pt) | composição farmacêutica contendo solifenacina | |
| EP2604264A4 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF VIRUS DISEASES |